The SIRveNIB abstract published on-line in the Journal of Clinical Oncology states that treatment of locally advanced Hepatocellular Carcinoma (HCC) with a single treatment of SIR-Spheres® Y-90 resin microspheres results in Overall Survival not significantly different from twice-daily oral sorafenib, but with significantly better tumour response and fewer and less severe adverse events.
The success of the SIRT Users' Network, called SUN, in its first 2 years has created a strong desire for other countries to join. It has been announced today that SUN will expand to include health professionals from the United Kingdom, Belgium, Spain and Italy.
The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has launched its CIRSE Registry for SIR-Spheres Therapy (CIRT), a new European-wide observational study that will gather data on patients with primary and secondary liver tumours treated with SIR-Spheres microspheres at specialist hospitals across Europe.
My SIRT story - the first dedicated UK patient website to provide information and support to patients, and their loved ones, about the life-extending liver cancer treatment, Selective Internal Radiation Therapy (SIRT).